Ophthalmic and Topical Dosage Form New Animal Drugs; 2-Mercaptobenzothiazole Solution
other · Food and Drug Administration · Rule · Published 2000-08-22 · Effective 2000-08-22 · 65 FR 50912
Document
Document number
00-21414
Federal Register citation
65 FR 50912
CFR reference
21 CFR 524
Type
Rule
Action
Final rule.
Category
other
Sub-agency
Food and Drug Administration
Publication date
2000-08-22
Effective date
2000-08-22
Abstract
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Combe, Inc. The supplemental NADA provides for the topical use of 2-mercaptobenzothiazole solution as an aid in the treatment of certain common skin inflammations in dogs.